Canada markets closed

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
30.74-1.20 (-3.76%)
At close: 04:00PM EDT
30.74 0.00 (0.00%)
After hours: 05:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.87B
Enterprise Value 1.55B
Trailing P/E 12.57
Forward P/E 24.57
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.09
Price/Book (mrq)3.34
Enterprise Value/Revenue 4.93
Enterprise Value/EBITDA 10.21

Trading Information

Stock Price History

Beta (5Y Monthly) 2.08
52-Week Change 322.61%
S&P500 52-Week Change 326.36%
52 Week High 333.34
52 Week Low 313.72
50-Day Moving Average 327.76
200-Day Moving Average 322.35

Share Statistics

Avg Vol (3 month) 3561.02k
Avg Vol (10 day) 3514.48k
Shares Outstanding 558.65M
Implied Shares Outstanding 658.65M
Float 843.03M
% Held by Insiders 11.24%
% Held by Institutions 1104.05%
Shares Short (Apr 30, 2024) 43.73M
Short Ratio (Apr 30, 2024) 46.86
Short % of Float (Apr 30, 2024) 46.46%
Short % of Shares Outstanding (Apr 30, 2024) 46.37%
Shares Short (prior month Mar 28, 2024) 43.44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 51.47%
Operating Margin (ttm)80.92%

Management Effectiveness

Return on Assets (ttm)21.38%
Return on Equity (ttm)41.75%

Income Statement

Revenue (ttm)314.95M
Revenue Per Share (ttm)5.31
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA 149.64M
Net Income Avi to Common (ttm)162.11M
Diluted EPS (ttm)2.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)322.64M
Total Cash Per Share (mrq)5.5
Total Debt (mrq)462k
Total Debt/Equity (mrq)0.08%
Current Ratio (mrq)15.72
Book Value Per Share (mrq)9.56

Cash Flow Statement

Operating Cash Flow (ttm)-63.32M
Levered Free Cash Flow (ttm)-154.68M